DK3858977T5 - Stamme til forebyggelse og behandling af stofskiftesygdomme, og brugen heraf - Google Patents
Stamme til forebyggelse og behandling af stofskiftesygdomme, og brugen heraf Download PDFInfo
- Publication number
- DK3858977T5 DK3858977T5 DK19864901.4T DK19864901T DK3858977T5 DK 3858977 T5 DK3858977 T5 DK 3858977T5 DK 19864901 T DK19864901 T DK 19864901T DK 3858977 T5 DK3858977 T5 DK 3858977T5
- Authority
- DK
- Denmark
- Prior art keywords
- strain
- prevention
- treatment
- metabolic diseases
- metabolic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811132882.1A CN110964650B (zh) | 2018-09-27 | 2018-09-27 | 一种用于预防和治疗代谢疾病的菌株及其应用 |
| PCT/CN2019/107757 WO2020063646A1 (zh) | 2018-09-27 | 2019-09-25 | 一种用于预防和治疗代谢疾病的菌株及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3858977T3 DK3858977T3 (da) | 2024-03-18 |
| DK3858977T5 true DK3858977T5 (da) | 2024-08-19 |
Family
ID=69952455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19864901.4T DK3858977T5 (da) | 2018-09-27 | 2019-09-25 | Stamme til forebyggelse og behandling af stofskiftesygdomme, og brugen heraf |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12036251B2 (da) |
| EP (1) | EP3858977B1 (da) |
| KR (1) | KR102662155B1 (da) |
| CN (1) | CN110964650B (da) |
| AU (1) | AU2019346903C1 (da) |
| CA (1) | CA3114471C (da) |
| DK (1) | DK3858977T5 (da) |
| ES (1) | ES2974171T3 (da) |
| WO (1) | WO2020063646A1 (da) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118340799A (zh) * | 2020-02-27 | 2024-07-16 | 上海上药信谊药厂有限公司 | 抗肿瘤组合物 |
| KR20220164002A (ko) * | 2020-04-03 | 2022-12-12 | 듀폰 뉴트리션 바이오사이언시즈 에이피에스 | 대사 건강 개선용 박테리아 균주를 포함하는 조성물 |
| CN112342154B (zh) * | 2020-09-03 | 2022-08-05 | 上海上药信谊药厂有限公司 | 用于预防和治疗女性生殖道炎症的益生菌 |
| US20230381246A1 (en) * | 2020-10-19 | 2023-11-30 | Duke University | Genetically diverse akkermansia strains and methods of using same |
| BE1028339B1 (fr) * | 2020-11-09 | 2021-12-21 | A Mansia Biotech | Composition comprenant de l'Akkermansia muciniphila et de l'extrait de thé vert |
| CN114451557A (zh) * | 2020-11-10 | 2022-05-10 | 中国人民解放军南部战区总医院 | Akk益生菌在制备防治中暑药物、食品或保健品中的应用 |
| CN113322202B (zh) * | 2021-05-31 | 2022-03-01 | 君维安(武汉)生命科技有限公司 | 一种阿克曼氏菌、其培养方法及其应用 |
| BE1029496B1 (fr) * | 2021-08-19 | 2023-01-16 | The Akkermansia Company | Composition comprenant de l'Akkermansia muciniphila pasteurisée pour le traitement ou la prévention des troubles de la contractilité intestinale, en particulier des troubles de l'amplitude de la contractilité duodénale |
| CN115252651B (zh) * | 2022-06-08 | 2024-06-07 | 广州知易生物科技有限公司 | 嗜粘蛋白阿克曼菌在制备防治高血压的组合物中的应用和含有其的组合物 |
| CN114949004B (zh) * | 2022-06-08 | 2024-04-26 | 广州知易生物科技有限公司 | 嗜黏蛋白阿克曼菌在制备防治高血脂的组合物中的应用及含有其的组合物 |
| CN115804793B (zh) * | 2022-06-08 | 2025-08-15 | 石家庄普维生物科技有限公司 | 嗜粘蛋白阿克曼菌在制备改善酒精性肝功能异常的组合物中的应用、组合物及应用 |
| CN114832019A (zh) * | 2022-06-08 | 2022-08-02 | 广州知易生物科技有限公司 | 嗜粘蛋白阿克曼菌在制备防治肥胖症的药物组合物中的应用、组合物及其应用 |
| CN116115647B (zh) * | 2022-06-08 | 2024-12-20 | 广州知易生物科技有限公司 | 嗜粘蛋白阿克曼菌在制备改善代谢综合征的药物组合物或保健品组合物中的应用 |
| CN114949002B (zh) * | 2022-06-08 | 2024-03-19 | 广州知易生物科技有限公司 | 嗜粘蛋白阿克曼菌在制备防治动脉粥样硬化的组合物中的应用 |
| CN115381859B (zh) * | 2022-06-08 | 2024-12-20 | 广州知易生物科技有限公司 | 嗜粘蛋白阿克曼菌在制备防治糖尿病的药物组合物中的应用、组合物及其应用 |
| CN116236507B (zh) * | 2023-02-27 | 2025-04-18 | 广州知易生物科技有限公司 | 嗜黏蛋白阿克曼氏菌在缓解和治疗精神分裂症中的应用 |
| JP7763003B2 (ja) * | 2023-02-28 | 2025-10-31 | エンテロバイオーム インコーポレイテッド | 生物学的治療剤の反応性予測方法及びそれを利用した多様な疾患の治療方法 |
| CN116200312B (zh) * | 2023-03-30 | 2023-08-22 | 广西爱生生命科技有限公司 | 一种抗氧化、减脂和抑制肿瘤生长的广西阿克曼氏菌及其产品与应用 |
| CN116999519B (zh) * | 2023-08-16 | 2024-11-12 | 江南大学 | 一种治疗高血脂症的药菌组合物及其制备方法和应用 |
| CN117018039B (zh) * | 2023-08-18 | 2025-04-01 | 善恩康生物科技（苏州）有限公司 | Akkermansia muciniphila在制备预防、治疗和/或辅助治疗代谢疾病的产品中的应用 |
| CN117903965A (zh) * | 2023-12-05 | 2024-04-19 | 杭州微致生物科技有限公司 | 一种嗜黏蛋白阿克曼氏菌vb202及其应用 |
| CN118178476A (zh) * | 2024-04-03 | 2024-06-14 | 暨南大学附属第一医院（广州华侨医院） | 阿克曼菌及其制剂在制备促进排便、排脂、减少肠道脂肪吸收的药物中的应用 |
| CN118178478B (zh) * | 2024-04-12 | 2025-01-24 | 善恩康生物科技（苏州）有限公司 | Akkermansia muciniphila及其产品在糖尿病防治中的应用 |
| CN118389344A (zh) * | 2024-05-06 | 2024-07-26 | 微康益生菌(苏州)股份有限公司 | 一种提高嗜黏蛋白阿克曼菌产业化离心收率的制备方法及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014DN07752A (da) * | 2012-02-29 | 2015-05-15 | Ethicon Endo Surgery Inc | |
| WO2014075745A1 (en) * | 2012-11-19 | 2014-05-22 | Université Catholique de Louvain | Use of akkermansia for treating metabolic disorders |
| US9846185B2 (en) * | 2013-02-27 | 2017-12-19 | Texas Instruments Incorporated | Capacitive sensing |
| CN105106245A (zh) * | 2015-08-24 | 2015-12-02 | 上海交通大学医学院附属瑞金医院 | Akkermansia muciniphila BAA-835菌株的应用 |
| WO2017060698A1 (en) * | 2015-10-05 | 2017-04-13 | Liam O'mahony | Use of akkermansia muciniphila for treating inflammatory conditions |
| KR101809172B1 (ko) * | 2016-07-11 | 2017-12-14 | 한국생명공학연구원 | 뮤신이 없는 배지에서 배양한 아커만시아 뮤시니필라 균주 또는 이의 배양액을 유효성분으로 함유하는 대사성 질환의 예방, 개선 또는 치료용 조성물 |
| EP3483256A4 (en) * | 2016-07-11 | 2019-12-04 | Korea Research Institute of Bioscience and Biotechnology | AKKERMANSIA MUCINIPHILA TRIBE WITH EFFECT FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES OR METABOLIC DISEASES AND USE THEREOF |
| EP3551201A4 (en) * | 2016-12-06 | 2020-06-24 | Pendulum Therapeutics, Inc. | METHODS AND COMPOSITIONS ASSOCIATED WITH INSULATED AND PURIFIED MICROBES |
| WO2019109348A1 (zh) * | 2017-12-08 | 2019-06-13 | 深圳华大生命科学研究院 | 丁酸杆菌(Butyribacter intestini)在预防和/或治疗炎症相关疾病的应用 |
| CN111944727B (zh) * | 2020-08-24 | 2021-12-03 | 汤臣倍健股份有限公司 | 一种短双歧杆菌207-1及其应用 |
-
2018
- 2018-09-27 CN CN201811132882.1A patent/CN110964650B/zh active Active
-
2019
- 2019-09-25 ES ES19864901T patent/ES2974171T3/es active Active
- 2019-09-25 US US17/278,662 patent/US12036251B2/en active Active
- 2019-09-25 CA CA3114471A patent/CA3114471C/en active Active
- 2019-09-25 AU AU2019346903A patent/AU2019346903C1/en active Active
- 2019-09-25 KR KR1020217012396A patent/KR102662155B1/ko active Active
- 2019-09-25 WO PCT/CN2019/107757 patent/WO2020063646A1/zh not_active Ceased
- 2019-09-25 DK DK19864901.4T patent/DK3858977T5/da active
- 2019-09-25 EP EP19864901.4A patent/EP3858977B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3858977B1 (en) | 2024-02-28 |
| CN110964650A (zh) | 2020-04-07 |
| AU2019346903C1 (en) | 2023-06-22 |
| AU2019346903A1 (en) | 2021-05-20 |
| EP3858977A4 (en) | 2022-06-01 |
| US20220031769A1 (en) | 2022-02-03 |
| WO2020063646A1 (zh) | 2020-04-02 |
| EP3858977A1 (en) | 2021-08-04 |
| CN110964650B (zh) | 2022-10-11 |
| CA3114471A1 (en) | 2020-04-02 |
| AU2019346903B2 (en) | 2022-12-15 |
| KR20210069663A (ko) | 2021-06-11 |
| ES2974171T3 (es) | 2024-06-26 |
| KR102662155B1 (ko) | 2024-04-29 |
| DK3858977T3 (da) | 2024-03-18 |
| US12036251B2 (en) | 2024-07-16 |
| CA3114471C (en) | 2025-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3858977T5 (da) | Stamme til forebyggelse og behandling af stofskiftesygdomme, og brugen heraf | |
| DK3673080T3 (da) | Antisense-oligomerer til behandling af lidelser og sygdomme | |
| DK3877052T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK3774789T3 (da) | BRM-målrettede forbindelser og tilhørende fremgangsmåder til anvendelse | |
| DK3402499T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes | |
| DK3717471T3 (da) | Nye forbindelser og lægemiddelsammensætninger heraf til behandling af sygdomme | |
| DK3789501T3 (da) | Fremgangsmåde til diagnosticering, behandling og forebyggelse af parkinsons sygdom | |
| DK3478679T3 (da) | 5,7-dihydro-pyrrolo-pyridin-derivater til behandling af neurologiske og neurodegenerative sygdomme | |
| DK3407889T3 (da) | Organiske forbindelser og deres anvendelse til behandling og forebyggelse af lidelser i centralnervesystemet | |
| DK3889145T3 (da) | 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme | |
| DK4014976T3 (da) | Aprocitentan til anvendelse i behandlingen af hypertension og relaterede sygdomme i kombination med valsartan | |
| DK3442580T3 (da) | Fremgangsmåder til behandling af kolestatiske og fibrotiske sygdomme | |
| DK3405215T3 (da) | Fremgangsmåder til behandling af danon-sygdom og andre autofagilidelser | |
| DK3277295T3 (da) | Sammensætning til behandling af en patogen, metabolisk tarmmikrobiotatilstand og afledte sygdomme | |
| DK3386523T3 (da) | Bifidobacterium longum til behandling af fedme og associerede metabolske sygdomme | |
| DK3387156T3 (da) | Lactobacillus casei til behandling af fedme og associerede metabolske sygdomme | |
| DK3328864T3 (da) | Terapeutiske forbindelser og sammensætninger til behandling af sociale forstyrrelser og stofmisbrugsforstyrrelser | |
| DK3947375T3 (da) | Imidazolonylquinolinforbindelser og terapeutiske anvendelser deraf | |
| IL269083A (en) | Methods for preventing and treating heart disease | |
| DK3310190T3 (da) | Sammensætning til behandling af kød og anvendelse af denne | |
| DK3615502T3 (da) | Terapeutiske forbindelser og fremgangsmåder | |
| DK3710590T3 (da) | Virale vektorer omfattende rdh12-kodende områder og fremgangsmåder til behandling af nethindedystrofier | |
| DK3157532T3 (da) | Fremgangsmåder til behandling og forebyggelse af sygdomme med vaskulær instabilitet | |
| DK3307323T3 (da) | Carbazolderivater til behandling af fibrotiske sygdomme og relaterede symptomer, og tilstande deraf | |
| DK3290525T3 (da) | Fremgangsmåde til screening af lægemiddel og terapeutisk mål der anvendes til behandling af alzheimers sygdom |